Cargando…
Efficacy and Patient Satisfaction of the Weekly DPP-4 Inhibitors Trelagliptin and Omarigliptin in 80 Japanese Patients with Type 2 Diabetes
OBJECTIVE: We investigated the efficacy, safety, and patient satisfaction of once-weekly DPP-4 inhibitors (DPP-4Is). METHODS: Either of two once-weekly DPP-4Is, trelagliptin or omarigliptin, was administered alone or in combination with other antidiabetic drugs in 80 outpatients with type 2 diabetes...
Autores principales: | Tosaki, Takahiro, Kamiya, Hideki, Yamamoto, Yuka, Himeno, Tatsuhito, Kato, Yoshiro, Kondo, Masaki, Yamada, Yuichiro, Inagaki, Akemi, Tsubonaka, Kaori, Oshiro, Chie, Katayama, Takami, Hayasaki, Tomoyo, Nakaya, Yuki, Fujiyoshi, Haruna, Nakamura, Jiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658520/ https://www.ncbi.nlm.nih.gov/pubmed/28883229 http://dx.doi.org/10.2169/internalmedicine.8184-16 |
Ejemplares similares
-
Sodium-glucose Co-transporter 2 Inhibitors Reduce the Abdominal Visceral Fat Area and May Influence the Renal Function in Patients with Type 2 Diabetes
por: Tosaki, Takahiro, et al.
Publicado: (2017) -
Is Regenerative Medicine Ready for Prime Time in Diabetic Polyneuropathy?
por: Himeno, Tatsuhito, et al.
Publicado: (2018) -
Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directions
por: Himeno, Tatsuhito, et al.
Publicado: (2019) -
Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
por: Himeno, Tatsuhito, et al.
Publicado: (2019) -
Not out of the woods yet: “Diabetic neuropathy” or “neuropathy associated with diabetes”?
por: Himeno, Tatsuhito, et al.
Publicado: (2022)